Ian T. Clark

This profile gathers the share dealings of Ian T. Clark across 7 companies, led by Guardant Health, Inc., Agios Pharmaceuticals, Inc. and Kite Pharma, Inc. Between 3 January 2017 and 4 August 2026, the trades on record add up to 102 filings.

On the market, this insider has only sold: 40 sales, €13.1M in total. Outside the open market, there are 10 share grants and 50 option exercises. Since January 2026: no purchases and 3 sales on the market.

The latest filing, published on 5 August 2026, reports an option exercise of €300k in Guardant Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.